Australia vs Lesotho: Treatment success rate for patients treated for MDR-TB
Australia
84.0%
in 2022
Lesotho
84.0%
in 2022
Australia rank
38th
Lesotho rank
38th
Treatment success rate for patients treated for MDR-TB over time
- Australia
- Lesotho
How they compare
Australia currently reports 84.0% against 84.0% in Lesotho, a difference of 0.0%.
The two have swapped places 5 times across 15 shared years of data; in 2008 it was Australia ahead.
Australia ranks 38th and Lesotho ranks 38th of 163 countries.
Across the 3 decades both report, Australia averaged higher in 2 and Lesotho in 1.
Head to head by decade
| Decade | Australia | Lesotho | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 72.0% | 64.0% | 8.0% | Australia |
| 2010s | 73.4% | 69.0% | 4.4% | Australia |
| 2020s | 75.7% | 77.3% | 1.7% | Lesotho |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Australia or Lesotho?
- Australia, at 84.0% against 84.0% in Lesotho as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Australia and Lesotho?
- 0.0%, with Australia ahead.
- How many years of comparable data are there for Australia and Lesotho?
- 15 years are reported by both, from 2008 to 2022.
- How do Australia and Lesotho rank globally for treatment success rate for patients treated for mdr-tb?
- Australia ranks 38th and Lesotho ranks 38th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.